STAT+: Boston Scientific cancels $230 million deal to buy Korean device company
Boston Scientific is scrapping its $230 million plan to buy a majority stake in M.I….
Category: Medicine
STAT+: Annexon’s trial of an eye disease drug missed by a mile. The company saw a bull’s eye
Annexon Biosciences said Wednesday that its experimental treatment for an eye disease called geographic atrophy…
STAT+: Immunotherapy turned brain cancers from ‘cold’ to ‘hot’ in mouse study, as clinical trials advance
LONDON — The promise of immunotherapies to treat cancer has yet to reach brain tumors….
Decoding Medicare: 10 Key Decisions and How They’re Made
https://reports.statnews.com/products/will-medicare-pay-for-it?utm_source=statnews.com&utm_campaign=May23_report&utm_medium=stat_reports_articlewidget2.0 Read Original Article: Decoding Medicare: 10 Key Decisions and How They’re Made »
STAT+: Congress took on high drug prices in Medicare. Now Biden wants to take it to Medicaid
WASHINGTON — The Biden administration wants to help states control Medicaid prescription drug costs by…
STAT+: Addiction treatment center founder indicted in sprawling fraud scheme
Over the last few years, Daniel Cleggett Jr. appeared to be living a charmed life….
STAT+: Pharmalittle: Biden administration proposes yearly audit for costliest Medicaid drugs; few at high risk of HIV take prevention pills
Top of the morning to you. The middle of the week is upon us and,…
STAT+: FDA delays decision on Sarepta’s gene therapy for Duchenne muscular dystrophy
The Food and Drug Administration is delaying by one month a decision on the approval…
.jpg)
We’ll soon have tools to protect infants against RSV. Can we put them to good use?
When scientists, physicians, and public health officials discuss RSV, the talk almost always turns to…
STAT+: Battle for the soul of Illumina is also a referendum on its CEO
On Thursday Illumina, the largest and most important maker of DNA sequencing technology, whose innovations…
Opinion: What if we’re talking about teens’ mental health too much?
Every day, it seems, is mental health awareness day. In the U.S., there’s Eating Disorders…
Opinion: Will AI soon diagnose politicians’ mental health conditions from afar?
For psychiatrists, Donald Trump’s third run for the presidency means that we’ll once again face…
Opinion: How ‘screen and refer’ systems fail to help patients
We’ve all had the experience of a doctor or other health care worker staring at…
STAT+: Congress highlighted a chemo drug’s price to blast PBMs — but it’s not a PBM issue
WASHINGTON — Congress blasted drug middlemen at a hearing Tuesday, with multiple lawmakers pointing to…
A deep dive on generative AI in health care, Pear sold for parts, and progress on stretchable skin
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
HIV rates decline in U.S., data show, but disparities persist
The newest accounting of HIV incidence in the United States is a mixed bag. Overall…
STAT+: Learning to treat long COVID could help those struggling with chronic fatigue syndrome, too
CONCORD, N.H. — Veronica Dane had always been active, from playing soccer as a kid…
STAT+: Pharmalittle: Pfizer and Novo disclose upbeat data on oral weight loss drugs; PBM trade group blasts House committee over hearing
Rise and shine, another busy day is on the way. We can tell because the…
FDA budget battles, prisons’ sobering Covid response & BIO’s CEO search is on
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter…
STAT+: Achieve Life Sciences drug helps smokers quit in trial but would face stiff competition if approved
Seattle biotech Achieve Life Sciences on Tuesday announced an experimental drug meant to help people…
STAT+: Biotech launches with $300 million, joint venture to expedite RNA drug development
Biotech venture capital may be pacing at a six-year low, but one startup just managed…
Social media risks for youth mental health highlighted in new surgeon general report
Amid what he called the worst youth mental health crisis in recent memory, U.S. Surgeon…
Opinion: Three ways to test medical AI for safety
This article is adapted from “The AI Revolution in Medicine: GPT-4 and Beyond,” by Peter…
What does generative AI mean for health care? We asked the experts
Health care companies are racing to incorporate generative AI tools into their product pipelines and…
‘Worse than what we thought’: New data reveals deeper problems with the Bureau of Prisons’ Covid response
WASHINGTON — The incarcerated people at Federal Medical Center Devens should have been some of…
ChatGPT in medicine: STAT answers readers’ burning questions about AI
Artificial intelligence is often described as a black box: an unknowable, mysterious force that operates…
Opinion: Cancer patients shouldn’t be responsible for out-of-pocket costs
In 2023, just under 2 million Americans will be diagnosed with cancer. Many will endure…
New nasal spray to reverse fentanyl and other opioid overdoses gets FDA approval
WASHINGTON — U.S. health regulators on Monday approved a new, easy-to-use version of a medication…
Routine screening for kidney disease would be cost-effective, study argues
In 2012, the United States Preventive Services Task Force convened to determine whether it should…
STAT+: Seagen criticized by shareholder advisory firm for ‘problematic’ executive compensation ahead of Pfizer acquisition
As Seagen prepares to be acquired by Pfizer, an investor advisory firm is raising concerns…
Novo says oral version of Ozempic leads to 15% weight loss
An oral version of semaglutide, the drug marketed as Ozempic and Wegovy, led to dramatic…
STAT+: Pharmalittle: Many employer health plans won’t pay for obesity drugs; FDA panel rejects Intercept NASH drug
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: Checklists to screen for patients’ social needs aren’t helping
I once saw a patient who came to the emergency room with injuries that were…
Making sense of AI research in medicine, in one slide
BOSTON — Scientific journals have become something of a Mad Libs game for GPT: Artificial…
‘A textbook case of environmental racism’: The battle over the Brookhaven Landfill
The area of North Bellport on Long Island sits in the shadows of a massive…
STAT+: In early trial, drug appears to reduce harmful protein buildup in heart
An early-stage drug for a heart disease called ATTR-CM showed potential to reverse disease progression,…
STAT+: In its first tough test, CRISPR epigenome editing cuts cholesterol levels in monkeys
A defanged form of CRISPR, which doesn’t slice or nick DNA, but rather alters the…
.jpg)
STAT+: Study: 1 in 5 primary endpoints changed in late-stage trials of cancer drugs already underway
Amid increased concerns over a lack of transparency in clinical trials, a new study found…
STAT+: FDA advisers vote against approving Intercept’s NASH drug
A panel of expert advisers to the Food and Drug Administration voted Friday against approving…
STAT+: FDA approves first treatment for skin condition that causes persistent wounds, a redosable gene therapy
The Food and Drug Administration on Friday approved the first treatment for a devastating condition…
STAT+: Novo Nordisk pauses ads for weight loss drug Wegovy as it struggles to meet demand
Novo Nordisk is pausing ads for its obesity drug Wegovy as it struggles to keep…
STAT+: FDA official offers insights into whether gene therapy makers could use common manufacturing process
WASHINGTON — A Food and Drug Administration official provided some insights this week into the…
STAT+: Pear Therapeutics sold for parts at $6 million auction
Four different companies agreed to buy the assets of Pear Therapeutics at auction on Thursday…
STAT+: Pharmalittle: AstraZeneca plans to ‘love’ China’s Communist Party; U.S. Supreme Court rules against Amgen in patent case
And so, another working week will soon draw to a close. Not a moment too…
After decades of neglecting women athletes, sport and exercise medicine is finally catching up
When cyclist Alison Tetrick joined the sport’s professional ranks, she received the perks that come…
Opinion: Chelsea Clinton: How to eliminate viral hepatitis by 2030
Viral hepatitis affects almost 400 million people and kills more than 1 million each year….
Opinion: How I helped Pfizer think through the ethics of Viagra 25 years ago
Twenty-five years ago, 75-year-old Bob Dole — former Republican presidential candidate and U.S. senator from…
Gene therapy death not caused by CRISPR, investigators confirm
Terry Horgan, the 27-year-old patient who died eight days after receiving a CRISPR therapy custom-built…
FDA advisory panel backs Pfizer’s RSV vaccine, but expresses some safety concerns
A committee of vaccine experts voted to recommend the Food and Drug Administration approve Pfizer’s…
Listen: The FTC v. Amgen, Sarepta’s future, & Galapagos’ turnaround
Does the FTC have it out for pharma? What does it take to make an…